Following its integration into the Eurofins network of companies in July, the newly added CAP-accredited facility brings anatomic, cytology, and molecular pathology expertise to the Eurofins Central Laboratory network. The team is recognized for its long-standing experience in women’s health, urology, and oncology studies. The addition strengthens Eurofins Central Laboratory’s ability to support sponsors and CROs with integrated pathology and molecular testing across global clinical trial programs.
Founded in 1984, DCL Pathology is a College of American Pathologists (CAP)-accredited lab and is internationally recognized as an expert provider of clinical trial pathology services, with specific expertise in women’s health, urology, and oncology studies.
The pathology facility is located in Carmel, IN. The site provides a comprehensive range of histology, cytology, pathology, and molecular pathology testing services, including DNA, RNA, and protein quantification, qPCR, and next-generation sequencing. This newly added service line is an outstanding complement to Eurofins Central Laboratory’s oncology offering, which is paramount in drug development.